Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody - Fierce Biotech

Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody - Fierce Biotech
Business

Listen to this article

0%

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected